Corrigendum to "Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine" [J. Virol. Method 332 (2025) 115079].

Autor: Moon SS; Centers for Disease Control and Prevention, Atlanta, GA, USA., Wang H; Centers for Disease Control and Prevention, Atlanta, GA, USA., Brown K; Centers for Disease Control and Prevention, Atlanta, GA, USA., Wang Y; Centers for Disease Control and Prevention, Atlanta, GA, USA., Bessey TK; Centers for Disease Control and Prevention, Atlanta, GA, USA., Greenberg HB; Department of Medicine and Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Jiang B; Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: bxj4@cdc.gov.
Jazyk: angličtina
Zdroj: Journal of virological methods [J Virol Methods] 2024 Dec 14, pp. 115100. Date of Electronic Publication: 2024 Dec 14.
DOI: 10.1016/j.jviromet.2024.115100
Databáze: MEDLINE
Externí odkaz: